Macrogenics Inc (MGNX) Company Profile & Statistics

Macrogenics Inc
MGNX
(Nasdaq - US)
N/A
14.54
+0.17 (+1.18%)
in:usd•As of: Apr 26, 2024 15:59 UTC -4
Open
14.85
High
14.94
Low
14.24

About Macrogenics Inc

CEO

Scott Koenig

Headquarters

9704 medical center drive

rockville, md 20850, united states

Auditor

Ernst & Young LLP

Employees

339

Share Holders

Website

www.macrogenics.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.

Macrogenics Inc Statistics

Valuation Measures

Market Capitalization ²	909.62M
Enterprise Value	808.67M
Enterprise Value/EBITDA (ttm)	-4.94
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	5.92
Price to Sales (ttm)	15.50
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	85.71%
Operating Margin (ttm)	-236.25%
Profit Margin (ttm)	5.35%
Return on Equity (ttm)	-88.49%
Return on Invested Capital (ttm)	-22.42%
Return on Assets (ttm)	-43.12%

Income Statement

Revenue (ttm)	58.75M
Revenue Per Share (ttm)	0.94
Gross Profit (ttm)	50.53M
EBITDA (ttm)³	-163.60M
Net Income Avi to Common (ttm)	-9.06M
Diluted EPS (ttm)	-0.16

Share Statistics

Beta (5Y Monthly)	2.09
52-Week Change	96.22%
S&P500 52-Week Change	25.74%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	62.43M
Dividend Yield	0.00%
Float ⁴	55.49M
% Held by Insiders	11.30%
% Held by Institutions	96.89%

Balance Sheet

Total Cash (mrq)	229.81M
Total Cash Per Share (mrq)	3.68
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.48%
Quick Ratio (mrq)	4.46%
Book Value Per Share (mrq)	2.46

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.26
Free Cash Flow (ytd)	-79.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Macrogenics Inc

Trade With A Regulated Broker